Delivery Order SPE2DB20D3304-SPE2DB25FW6P3

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $47,839.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,956,447 tablets of the medication Dasatinib 70 mg. The contract is a firm fixed-price agreement with an ultimate completion date of April 18, 2025. This contract is not set aside for any specific business category. Amerisourcebergen Drug...
This federal contract award, valued at $5,456.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568096600 - Dasatinib 20 mg Tablet 60s, a prescription medication, with a completion date of May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,035.19, is a firm-fixed-price delivery order for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,053.26, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a Firm Fixed Price delivery order without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,396.92, is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. The contract is not set aside and involves the delivery of a variety of pharmaceutical and medical products, including medications across multiple therapeutic domains such as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,545.94 contract is for the delivery of various medical and pharmaceutical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has a performance period that extends through April 2025. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,120.52, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price, non-set-aside award, allowing for open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,307.41, is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialty drugs. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a variety of medical and pharmaceutical products. The contract, valued at $784,784.64, has a firm fixed price and an ultimate completion date of March 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,724.29 order is under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW6P3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,632.41, is for the delivery of the medication Dasatinib 100 mg tablets. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:20 AM